EPISODE · Nov 25, 2024 · 54 MIN
New Frontiers in NSCLC: The Promise and Progress of HER2-Directed Therapies
from Keeping Current CME
Are you aware of the new therapies revolutionizing the treatment armamentarium for patients with HER2-mutated disease? Credit available for this activity expires: 11/25/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001833?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
New Frontiers in NSCLC: The Promise and Progress of HER2-Directed Therapies
0:00
54:17
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 54 minutes long.
When was this Keeping Current CME episode published?
This episode was published on November 25, 2024.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!